• Efficacy of diagnosis and treatment of pneumonia in pregnant women according to the modern European and national recommendations
To content Full text of article

Efficacy of diagnosis and treatment of pneumonia in pregnant women according to the modern European and national recommendations

PERINATOLOGY AND PEDIATRIC. UKRAINE. 2018.1(73):48-52; doi 10.15574/PP.2018.73.48

Lymanska A. Yu., Ohorodnyk A. O., Davydova Yu. V.
SI «Institute of Pediatrics, Obstetrics and Gynaecology of NAMS of Ukraine», Kyiv, Ukraine

Objective — to determine the efficacy of the drug Azaks (Nobel) in the treatment of pneumonia in pregnant women against extragenital pathology.
Material and methods. Eight pregnant women with community acquired pneumonia were under observation, out of those 4 patients with mild pneumonia and 4 with moderate course of disease. Five (41.6%) women had congenital heart defects, 3 (25%) hypertensive disease I grade, and 4 (33.3) women had heart defects of rheumatic origin. In all cases, pneumonia was associated with pre-existing acute viral infection. The pregnant women with mild pneumonia were administered Azax as monotherapy at a dose 500 mg once a day during 5 days, and the pregnant women with moderate pneumonia were administered comprehensive treatment (amoxicillin with clavulanic acid intravenously and azithromycin (Azax) orally) during 10 days.
Results. It was found high efficacy of antibiotic therapy with the use of azithromycin based on the treatment results in pregnant women. Examination the foetal status using ultrasound and Doppler echography revealed no negative effect of antibiotic therapy on maternal and foetal blood flow, as well as no signs of foetal growth retardation.
Conclusions. Treatment of pneumonia in pregnant women should comply with the standard treatment principles of adults. The high safety profile of azithromycin (Azax, Nobel) makes it possible to use it as an antibiotic therapy for pneumonia in pregnants of high-risk groups.
Key words: pregnancy, community acquired pneumonia, antibiotic therapy, azithromycin.


1. Banhidy F, Acs N, Puho EH, Czeizel AE. (2008). Maternal acute respiratory infectious diseases during pregnancy and birth outcomes. Eur J Epidemiol. 23:29—35. https://doi.org/10.1007/s10654-007-9206-2; PMid:18027089

2. Briggs GG, Freeman RK, Yaffe SJ. (2008). A Reference Guide to Fetal and Neonatal Risk Drugs and Lactation. 7th ed. Philadelphia (PA).

3. Cornella R, Graves MD. (2010). Pneumonia in pregnancy. Clin Obestet Gynecol.53:329—336. https://doi.org/10.1097/GRF.0b013e3181de8a6f; PMid:20436308

4. Garcia-Vidal C et al. (2009). Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin. Microbiol. Infect.15:1033—1038. https://doi.org/10.1111/j.1469-0691.2009.02918.x; PMid:19673961

5. Hewagama S, Walker SP, Stuart RL et al. (2010).2009 H1N1 Influenza A and Pregnancy Outcomes in Victoria, Australia. Clinical Infectious Diseases.50:686—690. https://doi.org/10.1086/650460; PMid:20100064

6. Louie JK, Acosta M, Jamieson DJ et al. (2009). Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California. The New England Journal of Medicine.362.1:27—35. https://doi.org/10.1056/NEJMoa0910444; PMid:20032319

7. Mandell LA, Wunderink RG, Anzueto A, Barteett JG, Campbell GD, Dean NC (2007). Infectious diseases society of America/American Thoracic society consensus guidelines on the management of community acquired pneumonia in adults. Clin Infect Dis. 44:27—72. https://doi.org/10.1086/511159; PMid:17278083

8. Nathwani D et al. (2008). Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J.Antimicrob.Chem.61:976—994. https://doi.org/10.1093/jac/dkn096; PMid:18339633

9. Seminars in Fetal and Neonatal Medicine. Congenital and Opportunistic Infections — Congenital and Opportunistic Infections (2007).12.3.

10. Tanaka T, Nakajima K, Murashima A et al. (2009). Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. Canadian Medical Association Journal.181.1—2:55—58.

11. WHO Weekly Epidemiological Record, 23 March (2007).12:82.93—104. http://www.who.int/wer.

12. Woodhead M et al. (2011). Guidelines for the management of adult lower respiratory tract infections — Full version. Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Clin. Microbiol. Infect.17.6:1—59. https://doi.org/10.1111/j.1469-0691.2011.03672.x; https://doi.org/10.1111/j.1469-0691.2011.03602.x; PMid:21951384